OBJECTIVE To describe the authors' experience using keratoprosthesis to treat pediatric corneal opacity. DESIGN Nonrandomized, consecutive, retrospective interventional series. PARTICIPANTS Twenty-two eyes of 17 children with opaque corneas as a result of primary congenital disease and or previous failed keratoplasty. METHODS A retrospective review of pediatric patients with a history of ...

Boston Keratoprosthesis Type 1 (KPro), an artificial cornea, is a therapeutic option for patients in need of corneal transplantation when the prognosis traditional keratoplasty guarded. Bandage contact lens wear essential post-operative management KPro eyes order to maintain adequate graft hydration, and minimize risk adverse complications. Suitable bandage selection imperative preserve keratop...

A 55-year-old nurse was referred with a 5-month history of right eye corneal abscess. The initial injury occurred when doing lawn work. The infection worsened despite multiple antibiotic, antiviral, and steroid treatments. Visual acuity was limited to hand motion. On examination, there was keratitis, ocular hypertension, and a secondary cataract. Corneal scrapings grew a filamentous fungus, ide...

In this case series of 74 patients with coexisting vitreoretinal injury and severe corneal opacification, after temporary keratoprosthesis (TKP) assisted pars plana vitrectomy (PPV), an allograft corneal transplant was not performed at the same time; instead, the patient's trephined corneal button was sutured back. One year after the surgery, if intraocular pressure of the injured eyes was abov...

A 70-year-old patient who underwent uneventful primary implantation of Auro K Pro (a Type I Boston Keratoprosthesis-based device), developed infiltrates in the deep stroma of the carrier corneal graft and exudates on the optic stem of the keratoprosthesis assembly, 6 weeks postoperatively, which subsequently progressed to endophthalmitis. Vitreous tap was positive for a panfungal polymerase cha...

PURPOSE To describe a surgical method for corneal pocket creation for KeraKlear keratoprosthesis implantation by PocketMaker microkeratome. METHODS We implanted keratoprosthesis KeraKlear in 3 patients. In all cases, we used a microkeratome PocketMaker to create a corneal pocket, where the incision was made at a depth of 300 µm with a vibrating diamond blade. RESULTS Although corneas have b...

PURPOSE To determine the factors influencing outcomes of Boston type I keratoprosthesis implantation in Stevens-Johnson syndrome (SJS) and to compare the results with those of individuals without SJS. METHODS This is a multicenter, retrospective, comparative consecutive case series of patients undergoing keratoprosthesis implantation in Los Angeles, Kolkata, and Manila. Statistical analysis w...

AIM To study the anatomical and visual performance following implantation of a model of artificial cornea and to evaluate the postoperative long term complications. METHODS 11 eyes of 11 patients with bilateral corneal blindness considered as potentially having high risk of failure of penetrating corneal keratoplasty were implanted with biocolonisable Kpro keratoprosthesis (BIOKOP I, FCI, Ran...

Standard keratoplasty is known to fail in eyes with refractory corneal blindness such as Stevens-Johnson syndrome, chemical burns, ocular cicatrical pemphigoid and multiple failed grafts. Keratoprosthesis (K-Pro) have improved the visual potential of these eyes glaucoma, which is often pre-existent, is a common complication and can compromise the results.This article reviews the underlying caus...